Can cloud-based tools accelerate Alzheimer's disease drug discovery?

Expert Opin Drug Discov. 2016;11(3):215-23. doi: 10.1517/17460441.2016.1141892. Epub 2016 Feb 3.

Authors

Ramón Cacabelos^{1

2}, Oscar Teijido^{1

3}, Juan C Carril^{1

4}

Affiliations

¹ a Chair of Genomic Medicine , Camilo José Cela University , Madrid , Spain.
² b EuroEspes Biomedical Research Center , Institute of Medical Science and Genomic Medicine , Corunna , Spain.
³ c Department of Medical Epigenetics , EuroEspes Biomedical Research Center , Corunna , Spain.
⁴ d Department of Genomics and Pharmacogenomics , EuroEspes Biomedical Research Center , Corunna , Spain.

PMID: 26766514
DOI: 10.1517/17460441.2016.1141892

No abstract available

Publication types

Editorial

MeSH terms

Alzheimer Disease / drug therapy*
Animals
Cloud Computing
Drug Design*
Drug Discovery / methods*
Humans